Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000458 · ClinicalTrials.gov registry record · Phase 2
Sertraline and Cognitive Therapy in Depressed Alcoholics
A Phase 2 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT00000458 is a Phase 2 study that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 100 participants.
The verdict
NCT00000458, a Phase 2 study, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study will assess whether individuals treated with sertraline (Zoloft) and cognitive behavior therapy will experience improvement with their depression and consume less alcohol than individuals treated with a placebo and cognitive behavior therapy. This is a 12-week, random assignment, placebo-controlled, double-blind study with followup assessments 1 and 3 months after treatment.
Interventions
- BEHAVIORAL cognitive behavior therapy
- DRUG sertraline (Zoloft)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Est. Completion | 2002-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000458
The ClinicalTrials.gov registry entry for NCT00000458 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which cognitive behavior therapy is the first listed.
NCT00000458 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000458 about?
NCT00000458 is a clinical study titled "Sertraline and Cognitive Therapy in Depressed Alcoholics". This study will assess whether individuals treated with sertraline (Zoloft) and cognitive behavior therapy will experience improvement with their depression and consume less alcohol than individuals treated with a placebo and cognitive behavior therapy. This is a 12-week, random assignment, placebo-...
What is the current status of trial NCT00000458?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. Estimated completion is 2002-01.
What interventions are being tested in trial NCT00000458?
The interventions under investigation include: cognitive behavior therapy (BEHAVIORAL), sertraline (Zoloft) (DRUG).
Who is sponsoring clinical trial NCT00000458?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.